“This is not about alarming people,” one researcher said. “It’s about recognizing an environmental factor that may be contributing to high blood pressure in some communities and making sure it’s part of the public health conversation." 

Abbott first warned the public about this problem in November. Now, for the second time in less than a month, the FDA is providing additional details. 

New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness. 

Cannabis use has been linked to multiple cardiovascular risks, but less is known about how it may affect patients who undergo major cardiac surgery.

The diet, named after the traditional eating habits of Greece and Italy, is already known for its benefits to the general public. Its impact on heart patients, however, was less clear. 

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately. 

Early evidence suggests CBD could help clinicians treat pericarditis, myocarditis and other significant heart conditions. Additional research is still required, however, including many more clinical trials.